Dosing of unfractionated heparin in obese patients with venous thromboembolism

Journal of General Internal Medicine

Volumn 26, Issue 5, 2011, Pages 487-491

  Hurewitz, Adam N ^a   Khan, Samar U ^b   Groth, Maritza L ^a   Patrick, Patricia A ^a   Brand, Donald A ^a,c  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b Vassar Brothers Hospital   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Anticoagulants administration dosage; Body weight; Heparin therapeutic use; Obesity; Thromboembolism drug therapy

Indexed keywords

HEPARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BODY MASS; CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; DOSE TIME EFFECT RELATION; FEMALE; HEPARINIZATION; HIGH RISK PATIENT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OBESITY; PARTIAL THROMBOPLASTIN TIME; PRESCRIPTION; RECOMMENDED DRUG DOSE; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPARIN; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; OBESITY; TIME FACTORS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 79958717135     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-010-1551-2     Document Type: Article

References (14)

1. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost. 2001;86:452-63. (Pubitemid 32663974)
2. Eichinger S, Hron G, Bialonczyk C, et al. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med. 2008;168:1678-83.
3. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Ann Intern Med. 1993;119:874-81. (Pubitemid 23316870)
4. Hull RD, Raskob GE, Rosenbloom D, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med. 1992;152:1589-95.
5. Hirsh J, Bauer KA, Donati MB, Gould M, Samama MM, Weitz JI. Parenteral anticoagulants. ACCP Evidence-Based Clinical Practice Guidelines (8th ed). Chest. 2008;133:141s-59s.
6. Wheeler AP, Jaquiss RD, Newman JH. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis. Arch Intern Med. 1988;148:1321-5.
7. Pollack CV Jr, Braunwald E. 2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med. 2008;51:591-606.
8. Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med. 1997;157:2562-8. (Pubitemid 27519975)
9. Bernardi E, Piccioli A, Oliboni G, Zuin R, Girolami A, Prandoni P. Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism - an overview. Thromb Hae-most. 2000;84:22-6. (Pubitemid 30433662)
10. Davidson BL, Büller HR, Decousus H, et al. Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials. J Thromb Hae-most. 2007;5:1191-4. (Pubitemid 46902121)
11. Barba R, Zapatero A, Losa JE, et al. Body mass index and mortality in patients with acute venous thromboembolism: findings from the RIETE registry. J Thromb Haemost. 2008;6:595-600. (Pubitemid 351404926)
12. Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med. 2005;118:978-80. (Pubitemid 41297761)
13. Caprini JA, Tapson VF, Hyers TM, et al. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. J Vasc Surg. 2005;42:726-33. (Pubitemid 41483500)
14. Hylek EM, Regan S, Henault LE, Gardner M, Chan AT, Singer DE, Barry MJ. Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis. Arch Intern Med. 2003;163:621-7. (Pubitemid 36314351)